Boston Scientific Corp
(NYSE:BSX)
$
90.75
0.54 (0.6%)
Market Cap: 133.75 Bil
Enterprise Value: 142.51 Bil
PE Ratio: 75.00
PB Ratio: 6.46
GF Score: 86/100 Boston Scientific Corp at Evercore ISI HealthCONx Virtual Conference Transcript
Dec 01, 2021 / 01:00PM GMT
Release Date Price:
$38.14
(+0.18%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD
Okay. Good morning, everyone. Thanks for joining us on day 2 and I'm super excited to kick day off with the Boston Scientific. We have from the company, Dave Pierce, who heads their -- President of Endoscopy; Dr. Brian Dunkin, the Chief Medical Officer of Endoscopy; and of course, Lauren Tengler, whom all of you know, who's heading Investor Relations at Boston. Dave, Brian and Lauren, thanks for taking the time this morning with us.
Lauren Tengler
Boston Scientific Corporation - Director of IR
Thanks, Vijay.
Brian J. Dunkin
Boston Scientific Corporation - VP of Medical Affairs - Endoscopy
Absolutely.
David A. Pierce
Boston Scientific Corporation - Executive VP and President of MedSurg & President of Endoscopy
Nice to be here.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot